Can COVID vaccine technology treat snakebites?

Yes, researchers are developing mRNA technology, similar to COVID vaccines, to protect against snakebite venom damage and reduce disabilities.

How does the new snakebite treatment from University of Reading work?

The University of Reading team designed mRNA to produce antibodies against snake venom toxins, delivered via lipid nanoparticles to protect muscle tissue.

What are the limitations of current snakebite treatments like antivenoms?

Current antivenoms are effective against toxins in the bloodstream but struggle to reach and repair damaged muscle tissue at the bite site.

Home / Health / COVID Tech Fights Snakebite Damage

COVID Tech Fights Snakebite Damage

24 Nov, 2025

•

Summary

mRNA technology from COVID vaccines shows promise against snakebite injuries.
This new approach could significantly reduce permanent disabilities from snakebites.
Researchers hope this tech could also combat toxins from other infections.

Scientists are exploring the potential of mRNA technology, pioneered for COVID-19 vaccines, to mitigate the severe injuries caused by snakebites. Early research indicates this approach can prevent muscle damage and reduce lasting disabilities, offering a significant advancement in treating venomous encounters. The technology aims to trigger the body's cells to produce antibodies specifically targeting venom toxins.

This novel method could overcome limitations of current antivenoms, which struggle to penetrate damaged muscle tissue at the bite site. By generating protective antibodies directly in affected areas, this mRNA-based treatment promises more effective protection. Researchers are optimistic about its potential, noting that the technology might also be applicable to combating toxins from bacterial infections.